Logo
x

Search category

Subscribe Now

PCSK9 Inhibitor Program

AstraZeneca Acquires Dogma Therapeutics' Oral PCSK9 Inhibitor Program

AstraZeneca Acquires Dogma Therapeutics' Oral PCSK9 Inhibitor Program

  • September 18, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.